Bhaskar Tare, director of Gloocal Communications, felicitated with Pride of Spandan Award 2024 for contribution in healthcare: Our Bureau, Mumbai Monday, December 23, 2024, 17:15 ...

StemCyte announces positive results from phase IIa trial of HPC, cord blood for treating post-Covid syndrome: Baldwin Park, California Monday, December 23, 2024, 17:00 Hrs [IST] S ...

US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...

Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...

GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae: Our Bureau, Bengaluru Monday, December 23, 2024, 14 ...

US FDA approves Mesoblast’s mesenchymal stromal cell therapy, Ryoncil for steroid-refractory aGvHD in children 2 months and older: Melbourne, Australia Monday, December 23, 2024 ...

Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101: Philadelphia Monday, December 23, 2024, 13:00 Hrs [IST] Vittoria Biotherapeutics, Inc, a clini ...

Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that the US Food and Drug Administration (FDA) has issued a ...

Myriad Genetics’ RiskScore named one of the top 10 significant advances in genomic medicine: Salt Lake City Monday, December 23, 2024, 11:00 Hrs [IST] Myriad Genetics, Inc, a le ...

Session on diagnosis and treatment illuminates latest advances in migraine diagnosis and treatment: Our Bureau, Mumbai Monday, December 23, 2024, 11:30 Hrs [IST] In a landmark eve ...

Saint-Herblain, France Monday, December 23, 2024, 09:00 Hrs [IST] ...

Nandita Vijayasimha, Bengaluru Monday, December 23, 2024, 08:00 Hrs [IST] ...